3 Results for "

BaF3-Tel-KDR cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BaF3-Tel-KDR cells" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109020
CAS No.: 1229453-99-9
Purity:  99.84%
Synonyms: LHA510
Target:  

VEGFR

Research Areas:  

Cardiovascular Disease

Acrizanib (LHA510) is a small-molecule vascular endothelial growth factor receptor 2 (VEGFR-2, KDR) inhibitor. Acrizanib inhibits the proliferation of BaF3-Tel-KDR cells dependent on VEGFR-2 activity, with an IC50 of 17.4 nM. Acrizanib can be used in research related to choroidal neovascularization and neovascular age-related macular degeneration .
loading...
    loading...
Cat. No.: HY-109020A
CAS No.: 1637434-72-0
Synonyms: LHA510 hydrochloride
Target:  

VEGFR

Research Areas:  

Cardiovascular Disease

Acrizanib hydrochloride (LHA510 hydrochloride) is a small-molecule vascular endothelial growth factor receptor 2 (VEGFR-2, KDR) inhibitor. Acrizanib hydrochloride inhibits the proliferation of BaF3-Tel-KDR cells dependent on VEGFR-2 activity, with an IC50 of 17.4 nM. Acrizanib hydrochloride can be used in research related to choroidal neovascularization and neovascular age-related macular degeneration .
loading...
    loading...
Cat. No.: HY-109020R
CAS No.: 1229453-99-9
Synonyms: LHA510 (Standard)
Research Areas:  

Cardiovascular Disease

Acrizanib (Standard) (LHA510 (Standard)) is the analytical standard of Acrizanib (HY-109020). This product is intended for research and analytical applications. Acrizanib (LHA510) is a small-molecule vascular endothelial growth factor receptor 2 (VEGFR-2, KDR) inhibitor. Acrizanib inhibits the proliferation of BaF3-Tel-KDR cells dependent on VEGFR-2 activity, with an IC50 of 17.4 nM. Acrizanib can be used in research related to choroidal neovascularization and neovascular age-related macular degeneration .
loading...
    loading...